Removal of aluminum during hemodialysis: effect of different dialyzer membranes.
Aluminum toxicity is now widely recognized as a major cause of morbidity in patients on maintenance hemodialysis. Desferrioxamine (DFO) chelation therapy has been suggested as a method of AI removal in such patients, though the most appropriate treatment schedule is yet to be established. In the present study, AI removal following DFO infusion was evaluated using two different dialyzer membranes to test the hypothesis that polyacrilonitrile (PAN) membranes permit better AI clearance. All patients studied had significantly elevated plasma AI concentrations (1.22 to 9.45 mumol/L; normal less than 0.56 mumol/L). Plasma AI did not correlate with estimated total AI intake. During hemodialysis with a cuprophane membrane, AI clearance ranged from 33.5 to 42.1 mL/min. Total AI removal was 192.2 +/- 90.4 mumol during cuprophane dialysis. During hemodialysis with a PAN membrane, AI clearance ranged from 35.7 to 54 mL/min. Total AI removal was 154.2 to 93.9 mumol during PAN dialysis. The differences in AI clearance and total AI removal were not statistically significant. It is concluded that use of a PAN membrane does not significantly enhance DFO-AI clearance.
D000180:Acrylic Resins; D000328:Adult; D000368:Aged; D000535:Aluminum / Q000097:blood*; D002482:Cellulose / Q000031:analogs & derivatives; D003676:Deferoxamine / Q000627:therapeutic use; D006801:Humans; D007688:Kidneys, Artificial; D008567:Membranes, Artificial; D008875:Middle Aged
D000180:Acrylic Resins; D008567:Membranes, Artificial; C010504:polyacrylonitrile; D002482:Cellulose; C009865:cuprammonium cellulose; D000535:Aluminum; D003676:Deferoxamine